Evaluation of OraQuick® HIV-1/2 as oral rapid test

African Journal of Infectious Diseases

Volumn 7, Issue 2, 2013, Pages 27-30

  Nkenfou, Celine Nguefeu ^a,b   Kembou, Japhette Esther ^a,c   Temgoua, Edith Saounde ^a   Djikeng, Appolinaire ^d   Mouafo, Linda Mekue ^a,c   Ndzie, Elvis Ndukong ^a,c   Donkam, Irenee ^b   Colizzi, Vitorrio ^e   SanouSobzé, Martin ^c  

^a Chantal Biya International Reference Centre   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF DSCHANG   (Cameroon)

^d International Livestock Research Institute   (Kenya)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Diagnostic kits; National algorithm; OMT based test; OraQuick

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PREDICTIVE VALUE;

EID: 84882961299     PISSN: 20060165     EISSN: None     Source Type: Journal    
DOI: 10.4314/ajid.v7i2.2     Document Type: Article

References (18)

1. Aghokeng, A. F., Mpoudi-Ngole, E. and Dimodi, H. (2009). Inaccurate diagnosis of HIV- 1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS One., 4(11): e7702.
2. Alemnji, A. G., Ngulefac G. A, Ndumbe, P. M. and Asonganyi, T. (2009). Field Evaluation of Calypte's AWARE TM Blood Serum Plasma (BSP) and Oral Mucosal Transudate (OMT) Rapid Tests for Detecting Antibodies to HIV-1 and 2 in Plasma and Oral Fluid. The Open AIDS Journal, 3: 14-18.
3. Bhore, A. V., Sastry, J., Patke, D., Gupte, N., Bulakh, P. M. and Lele, S. (2003). Sensitivity and specificity of rapid HIV testing of pregnant women in India. Int J STD AIDS, 14:37-41.
4. CDC/WHO/APHL (2001). Directives for the appropriate evaluation of HIV screening techniques in Africa, P53.
5. Constantine, N. T. and Zink, H. (2005). HIV testing technologies after two decades of evolution. Indian J Med Res, 121:519-538.
6. Delaney, K. P., Bernard, M.B., Apura, U., Peter, R. K., Patrick, A. K., Krishna, J., Ann, D.G., Denise, J.J. and Marc, B. (2006). Performance evaluation of an oral fluid rapid HIV1/2 test: experience from four CDC studies. AIDS, 20: 1655-1660.
7. Gregson, S., Zhuwau, T., Ndlovu, J. and Nyamukapa, C.A. (2002). Methods to reduce social desirability bias in sex surveys in low-development settings: Experience in Zimbabwe. Sex Transm Dis, 29:568-575.
8. Keenan, P. A., Keenan, J. M. and Branson, B. M. (2005). Rapid HIV testing. Wait time reduced from days to minutes. Postgrad Med, 117: 47-52.
9. National Institute of Statistics, preliminary report on HIV prevalence in Cameroon, February 2012.
10. Ndembi, N., Ngansop, C., Moudourou, S., Tayou, T. C., Abimiku, A., Mbanya, D. S. and Kaptue, L.N. (2011). Can oral fluid testing be used to replace blood-based HIV Rapid testing to scale up access to diagnosis and treatment in Cameroon? J. Acquir Immune Defic Syndr, 56 (4): e115-7.
11. O'Connell, R. J., Merritt, T. M., Malia, J. A., VanCott, T. C., Dolan, M. J. and Zahwa, H. (2003). Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol, 41:2153-5.
12. OraQuick Advanced HIV 1/2 Antibody Test (package insert) (2006). Bethlehem, Pennsylvania: Orasure Technologies, Inc; Accessed 14 June 2006.
13. Orasure Technologies Inc. OraQuick ADVANCE Rapid HIV1/2 antibody test product insert. www.orasure.com, (Last accessed July 25, 2012). Bethléem, PA 18015 USA.
14. Sangare, K. A., Koffi, A. R., Coulibaly, I. M. and Doulourou, C. (1997). Could saliva be used to detect HIV seroconversion? Sante, 7: 303-307.
15. Sophie, J. S., Pascoe, Lisa, F., Langhaug, Mudzori, J., Burke, E., Hayes, R., Frances M. and Cowan (2009). Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe. AIDS Patient Care STDS, 23(7): 571-576.
16. UNAIDS/WHO recommendations (1998). The importance of simple/rapid assays in HIV testing. Weekly Epidemiologic Record, 73:321-328.
17. UNAIDS/WHO. (2001). Guidelines for using HIV testing technologies in surveillance: Selection, evaluation and implementation. UNAIDS/01.22E.WHO/CDS/ CSR/EDC; 16.
18. Zelin, J., Garrett, N. and Saunders, J. (2008). An evaluation of the performance of OraQuick® ADVANCE rapid HIV-1/2 test in a high-risk population attending genito-urinary medicine clinics in East London, UK. Int. J. STD AIDS., 19:665-667.